Intimation of Allotment of shares under the Employee Stock Option Plan 2016

August 10, 2026 To, To, National Stock Exchange of India Limited, BSE Limited, “Exchange Plaza”, Corporate Relationship Department, 5th Floor, Plot No. C/1, G Block, 2nd Floor, New Trading Ring, Bandra- Kurla Complex, Bandra (East), P.J. Towers, Dalal Street, Mumbai – 400 051 Mumbai – 400 001 Scrip Name: GLENMARK Scrip Code: 532296 ISIN: INE935A01035 ISIN: INE935A01035 Our Reference No. 44/26-27 Our Reference No. 44/26-27 Dear Sir / Madam, Sub: Intimation of Allotment of shares under the Employee Stock Option Plan 2016 (ESOP 2016) This is to inform you that the Company has allotted 23,863 (Twenty-Three Thousand Eight Hundred and Sixty-Three) Equity Shares of Re. 1/- (Rupee One only) each on August 10, 2026, to the grantee who had exercised the options under the Company's Employee Stock Option Plan 2016 (ESOP 2016). With this allotment, the paid-up capital of the Company has increased from Rs. 28,22,00,809 divided into 28,22,00,809 number of equity shares of face value Re. 1/- each to Rs. 28,22,24,672 divided into 28,22,24,672 number of equity shares of face value Re. 1/- each. The details as required under the SEBI (Share Based Employee Benefits and Sweat equity) Regulations, 2021 are enclosed as Annexure – I. Thanking you, Yours faithfully, For Glenmark Pharmaceuticals Limited Rashmi Khandelwal Company Secretary & Compliance Officer ACS: 28839 Encl: As above Glenmark Pharmaceuticals Limited Glenmark House, B D Sawant Marg, Andheri (E), Mumbai 400 099 T: 91 22 4018 9999 F: 91 22 4018 9988 CIN No: L24299MH1977PLC019982 W: www.glenmarkpharma.com Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026 E: complianceofficer@glenmarkpharma.com Annexure-I 1. Company Name and address of Registered Glenmark Pharmaceuticals Limited Office Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026 2. Name of the Stock Exchanges on which the 1) BSE Limited Company’s shares are listed 2) The National Stock Exchange of India Limited 3. Filing date of the statement referred in September 6, 2016 Regulation 10(b) of the SEBI (Share Based Employee Benefits) Regulations, 2021 with Stock Exchange 4. Filing Number, if any In-Principle Approval Letter: BSE: DCS/IPO/ST/ESOP-IP/1319/2016-17 NSE: NSE/LIST/88702 5. Title of the Scheme pursuant to which Glenmark Pharmaceuticals Limited - shares are issued, if any Employee Stock Option Scheme, 2016 6. Kind of security to be listed Equity Shares 7. Par value of the shares 1 8. Date of issue of shares August 10, 2026 (Date of allotment on exercise) 9. Number of shares issued 23,863 10. Share Certificate No., if applicable Not applicable 11. Distinctive number of the share, if 282200810 to 282224672 applicable 12. ISIN Number of the shares if issued in INE935A01035 Demat 13. Exercise price per share 600 14. Premium per share 599 15. Total Issued shares after this issue 28,22,24,672 16. Total Issued share capital after this issue Rs. 28,22,24,672 17. Details of any lock-in on the shares Not applicable 18. Date of expiry of lock-in Not applicable 19. Whether shares identical in all respects to Yes, the shares rank pari passu with the existing shares if not, when will they existing shares become identical? 20. Details of listing fees, if payable Not applicable For Glenmark Pharmaceuticals Limited Rashmi Khandelwal Company Secretary & Compliance Officer ACS: 28839 Glenmark Pharmaceuticals Limited Glenmark House, B D Sawant Marg, Andheri (E), Mumbai 400 099 T: 91 22 4018 9999 F: 91 22 4018 9988 CIN No: L24299MH1977PLC019982 W: www.glenmarkpharma.com Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026 E: complianceofficer@glenmarkpharma.com